Physician profile
Bruce E Andrea
NPI 1609841949
$1,572.84
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $114 · 2021: $525 · 2022: $119 · 2023: $99.01 · 2024: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $539.90 | 2021-2022 | |
| Amgen INC. | $182.68 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $134.93 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.09 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $91.96 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $90.68 | 2019 | |
| Cvrx, INC. | $80.19 | 2022-2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $78.13 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $71.19 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $56.96 | 2023-2024 | |
| Boston Scientific Corporation | $56.96 | 2022-2024 | Jetstream Sc |
| United Therapeutics Corporation | $36.38 | 2019-2020 | |
| Pfizer INC. | $22.96 | 2019 | |
| Bardy Diagnostics, INC. | $14.00 | 2021 | |
| Amarin Pharma, INC. | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Andrea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.